XML 62 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Purchase Price Allocation of RayzeBio Acquisition (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Feb. 26, 2024
Dec. 31, 2023
Business Acquisition [Line Items]      
Goodwill $ 21,738   $ 21,169
RayzeBio      
Business Acquisition [Line Items]      
Cash and cash equivalents   $ 501  
Other assets   70  
Intangible assets   3,700  
Deferred income tax asset   81  
Deferred income tax liability   (798)  
Other liabilities   (109)  
Identifiable net assets acquired   3,445  
Goodwill   428  
Total consideration allocated   $ 3,873